[1]
“BLEEDING RISK IN SUBJECTS WITH SEVERE HEMOPHILIA ON VERY LOW DOSE AHF PROPHYLAXIS- AN OBSERVATIONAL STUDY”, Int. Res. J. Pharm., vol. 12, no. 8, pp. 77–80, Aug. 2021, doi: 10.56802/pcbqw596.